Calculation
Operating profit margin | = | 100 | × | Operating income1 | ÷ | Revenues1 | |
---|---|---|---|---|---|---|---|
Dec 31, 2023 | 16.00% | = | 100 | × | 6,859) | ÷ | 42,857) |
Dec 31, 2022 | 18.69% | = | 100 | × | 8,393) | ÷ | 44,915) |
Dec 31, 2021 | 25.57% | = | 100 | × | 10,028) | ÷ | 39,211) |
Dec 31, 2020 | 24.19% | = | 100 | × | 7,794) | ÷ | 32,218) |
Dec 31, 2019 | 17.99% | = | 100 | × | 4,594) | ÷ | 25,542) |
Dec 31, 2018 | 15.53% | = | 100 | × | 3,783) | ÷ | 24,358) |
Dec 31, 2017 | 14.19% | = | 100 | × | 2,968) | ÷ | 20,918) |
Dec 31, 2016 | 13.40% | = | 100 | × | 2,449) | ÷ | 18,274) |
Dec 31, 2015 | 13.77% | = | 100 | × | 2,336) | ÷ | 16,965) |
Dec 31, 2014 | 14.82% | = | 100 | × | 2,503) | ÷ | 16,890) |
Dec 31, 2013 | 12.30% | = | 100 | × | 1,610) | ÷ | 13,090) |
Dec 31, 2012 | 11.85% | = | 100 | × | 1,482) | ÷ | 12,510) |
Dec 31, 2011 | 10.62% | = | 100 | × | 1,245) | ÷ | 11,726) |
Dec 31, 2010 | 11.72% | = | 100 | × | 1,265) | ÷ | 10,789) |
Dec 31, 2009 | 10.38% | = | 100 | × | 1,049) | ÷ | 10,110) |
Dec 31, 2008 | 11.71% | = | 100 | × | 1,229) | ÷ | 10,498) |
Dec 31, 2007 | 10.00% | = | 100 | × | 974) | ÷ | 9,746) |
Dec 31, 2006 | 6.38% | = | 100 | × | 242) | ÷ | 3,792) |
Dec 31, 2005 | 10.01% | = | 100 | × | 263) | ÷ | 2,633) |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).
1 US$ in millions
Comparison to Competitors
Thermo Fisher Scientific Inc. | AbbVie Inc. | Amgen Inc. | Danaher Corp. | Gilead Sciences Inc. | Moderna Inc. | Regeneron Pharmaceuticals Inc. | |
---|---|---|---|---|---|---|---|
Dec 31, 2023 | 16.00% | 23.49% | 29.35% | 21.77% | 28.24% | -63.54% | 30.85% |
Dec 31, 2022 | 18.69% | 31.21% | 38.57% | 27.61% | 27.17% | 51.10% | 38.93% |
Dec 31, 2021 | 25.57% | 31.89% | 31.44% | 25.35% | 36.72% | 75.22% | 55.67% |
Dec 31, 2020 | 24.19% | 24.81% | 37.70% | 18.99% | 16.72% | -381.82% | 42.09% |
Dec 31, 2019 | 17.99% | 39.03% | 43.57% | 18.25% | 19.38% | — | 28.10% |
Dec 31, 2018 | 15.53% | 19.49% | 45.55% | 17.11% | 37.83% | — | 37.77% |
Dec 31, 2017 | 14.19% | 33.99% | 45.76% | 16.48% | 55.04% | — | 35.41% |
Dec 31, 2016 | 13.40% | 36.60% | 44.74% | 16.29% | 58.87% | — | 27.38% |
Dec 31, 2015 | 13.77% | 32.97% | 40.44% | 16.87% | 69.03% | — | 30.51% |
Dec 31, 2014 | 14.82% | 17.09% | 32.03% | 17.23% | 62.37% | — | 29.74% |
Dec 31, 2013 | 12.30% | 30.14% | 32.25% | 17.13% | 41.87% | — | 36.11% |
Dec 31, 2012 | 11.85% | 31.65% | 33.52% | 17.33% | 42.67% | — | 33.20% |
Dec 31, 2011 | 10.62% | — | 28.19% | 16.27% | 46.77% | — | -46.02% |
Dec 31, 2010 | 11.72% | — | 37.82% | 16.41% | 53.62% | — | -21.23% |
Dec 31, 2009 | 10.38% | — | 38.37% | 13.79% | 54.55% | — | -19.54% |
Dec 31, 2008 | 11.71% | — | 35.50% | 14.72% | 52.68% | — | -37.67% |
Dec 31, 2007 | 10.00% | — | 27.81% | 15.79% | 57.98% | — | -91.55% |
Dec 31, 2006 | 6.38% | — | 27.71% | 15.82% | -29.32% | — | -169.68% |
Dec 31, 2005 | 10.01% | — | 40.33% | 15.84% | 61.41% | — | -187.97% |
Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).